IRADIMED CORPORATION (IRMD)
NASDAQ: IRMD · Real-Time Price · USD
52.55
+0.52 (1.00%)
Oct 29, 2024, 4:00 PM EDT - Market closed
IRADIMED CORPORATION Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 69.48 | 65.56 | 53.3 | 41.81 | 31.72 | 38.52 | Upgrade
|
| Revenue Growth (YoY) | 16.05% | 23.00% | 27.48% | 31.83% | -17.65% | 26.54% | Upgrade
|
| Cost of Revenue | 15.84 | 15.4 | 12.02 | 9.76 | 8.14 | 8.82 | Upgrade
|
| Gross Profit | 53.65 | 50.16 | 41.28 | 32.05 | 23.57 | 29.7 | Upgrade
|
| Selling, General & Admin | 29.52 | 27.3 | 23.41 | 20.36 | 19.76 | 19.65 | Upgrade
|
| Research & Development | 2.69 | 2.82 | 2.24 | 1.87 | 1.87 | 1.4 | Upgrade
|
| Operating Expenses | 32.21 | 30.12 | 25.65 | 22.23 | 21.63 | 21.05 | Upgrade
|
| Operating Income | 21.44 | 20.04 | 15.63 | 9.82 | 1.94 | 8.65 | Upgrade
|
| Interest & Investment Income | 1.86 | 1.86 | 0.58 | 0.03 | 0.13 | 0.39 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.15 | -0.15 | -0.04 | -0.03 | -0.01 | -0 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.46 | - | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | 23.62 | 21.75 | 16.17 | 9.82 | 2.07 | 9.03 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | 0.01 | 0.02 | 0.02 | 0.01 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.01 | -0.01 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | -2.7 | - | Upgrade
|
| Pretax Income | 23.6 | 21.74 | 16.18 | 9.84 | -0.62 | 9.04 | Upgrade
|
| Income Tax Expense | 4.96 | 4.55 | 3.35 | 0.51 | -1.99 | -0.59 | Upgrade
|
| Net Income | 18.64 | 17.19 | 12.83 | 9.33 | 1.37 | 9.63 | Upgrade
|
| Net Income to Common | 18.64 | 17.19 | 12.83 | 9.33 | 1.37 | 9.63 | Upgrade
|
| Net Income Growth | 26.95% | 34.02% | 37.56% | 581.19% | -85.79% | 52.79% | Upgrade
|
| Shares Outstanding (Basic) | 13 | 13 | 13 | 12 | 12 | 11 | Upgrade
|
| Shares Outstanding (Diluted) | 13 | 13 | 13 | 13 | 12 | 12 | Upgrade
|
| Shares Change (YoY) | 0.61% | 0.69% | 0.36% | 1.21% | 1.33% | 1.37% | Upgrade
|
| EPS (Basic) | 1.48 | 1.36 | 1.02 | 0.76 | 0.11 | 0.85 | Upgrade
|
| EPS (Diluted) | 1.46 | 1.35 | 1.02 | 0.74 | 0.11 | 0.78 | Upgrade
|
| EPS Growth | 25.06% | 32.35% | 37.84% | 572.73% | -85.90% | 50.00% | Upgrade
|
| Free Cash Flow | 13.58 | 6.02 | 9.22 | 10.78 | 5.37 | 9.86 | Upgrade
|
| Free Cash Flow Per Share | 1.07 | 0.47 | 0.73 | 0.86 | 0.43 | 0.80 | Upgrade
|
| Dividend Per Share | 0.300 | 0.150 | - | - | - | - | Upgrade
|
| Gross Margin | 77.21% | 76.50% | 77.45% | 76.65% | 74.33% | 77.11% | Upgrade
|
| Operating Margin | 30.86% | 30.56% | 29.32% | 23.48% | 6.13% | 22.45% | Upgrade
|
| Profit Margin | 26.83% | 26.22% | 24.07% | 22.30% | 4.32% | 25.00% | Upgrade
|
| Free Cash Flow Margin | 19.55% | 9.19% | 17.30% | 25.77% | 16.94% | 25.61% | Upgrade
|
| EBITDA | 22.26 | 20.8 | 16.3 | 11.22 | 3.28 | 9.89 | Upgrade
|
| EBITDA Margin | 32.04% | 31.73% | 30.58% | 26.84% | 10.35% | 25.68% | Upgrade
|
| D&A For EBITDA | 0.82 | 0.77 | 0.67 | 1.41 | 1.34 | 1.24 | Upgrade
|
| EBIT | 21.44 | 20.04 | 15.63 | 9.82 | 1.94 | 8.65 | Upgrade
|
| EBIT Margin | 30.86% | 30.56% | 29.32% | 23.48% | 6.13% | 22.45% | Upgrade
|
| Effective Tax Rate | 21.01% | 20.91% | 20.72% | 5.19% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.